PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Rheumatology and Clinical Immunology, Department of Medicine IV, Ludwig Maximilians University of Munich, Munich, Germany hendrik.schulze-koops@med.uni-muenchen.de.\', \'Klinik für Rheumatologie und Klinische Immunologie, KEM Kliniken Essen-Mitte, Essen, Germany.\', \'Division of Rheumatology and Clinical Immunology, Department of Medicine IV, Ludwig Maximilians University of Munich, Munich, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • e00155310.1136/rmdopen-2020-001553
?:doi
?:hasPublicationType
?:journal
  • RMD open
is ?:pmid of
?:pmid
?:pmid
  • 33627439
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.169
?:rankingScore_hIndex
  • 13
?:title
  • Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33627439>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33627439>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all